author-photo

Robert B. Geller

Emory University

27

Papers

1009

Citations

Citation Trend

Filter By

Papers (22) Sort By

Journal Conference Others

Letter to the Editor Regarding “The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence”

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomiting

2019 Journal of Comparative Effectiveness Research
Show All
- Source
- Cite
- Save
Citations (2)
Single agent cloretazine is an effective induction therapy in elderly patients (pts) with poor risk AML

2006 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (0)
Poor risk assessment in the elderly receiving cloretazine induction for AML or MDS

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I Study of Cloretazine® and Temozolomide in Patients with Hematologic Malignancies.

2006 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Cloretazine is an effective induction therapy in elderly patients (pts) with poor-risk de novo AML

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

2000 Blood
Show All
- Source
- Cite
- Save
Citations (90)
Oral chemotherapy agents in the treatment of leukaemia.

1999 Drugs
- Robert B. Geller
- Suzanne P. Dix
Show All
- Source
- Cite
- Save
Citations (5)
Efficacy of Low-Dose Dopamine in Preventing Amphotericin B Nephrotoxicity in Bone Marrow Transplant Patients and Leukemia Patients

1998 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (21)
Impact of donor lymphocyte infusion for hematological malignancy relapsed after allogeneic bone marrow transplantation

1998
Show All
- Source
- Cite
- Save
Citations (4)